plc (NYSE: MNK) today announced that its subsidiary, Cadence
Pharmaceuticals, Inc., has entered into settlement and license
agreements with Fresenius Kabi USA, LLC, resolving pending patent
litigation involving OFIRMEV ® (acetaminophen) injection.
Sign-up for - Mentor Graphics Vice President of Corporate Development and Investor Relations, Joseph Reinhart, to Present at the 16th Annual Pacific Crest Global Technology Leadership Forum investment picks
SAN FRANCISCO (MarketWatch) - Keurig Green Mountain (GMCR) on Wednesday reported a fiscal third-quarter profit of $155.2 million, or 94 cents a share, compared with a profit of $116.3 million, or 76 cents a share, for the year-earlier period.
Total product revenues double to $28.2 million from Q2 2013 $224 million cash on hand, up over $10 million in the quarter Conference call scheduled for today at 4:30 PM EDT
Dial in information included below NEWARK, Calif.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.